Pharmacodynamic of Recombinant Human Interferon Alpha-2b Nasal Drops and Effective Prophylaxis Against SARS-COV-2 Infection
J Interferon Cytokine Res
.
2024 Apr 10.
doi: 10.1089/jir.2023.0193.
Online ahead of print.
Authors
Hugo Nodarse-Cuni
1
,
Odalys Bravo
2
,
Roberto Cañete
3
,
Dania Vázquez-Blomquist
4
,
Diogenes Quintana
4
,
Ana Aguilera-Barreto
5
,
Gerardo Guillen-Nieto
4
,
Amaylid Arteaga
6
,
Ileana Morales
2
Affiliations
1
Clinical Research Department, Center for Genetic Engineering and Biotechnology, La Habana, Cuba.
2
National Science and Innovation Directorate, Ministry of Public Health, Havana, Cuba.
3
Research Department, Medical College of Matanzas, Matanzas, Cuba.
4
Biomedical Research Department, Center for Genetic Engineering and Biotechnology, La Habana, Cuba.
5
Technological Development Department, Center for Genetic Engineering and Biotechnology, Havana, Cuba.
6
Research Department, National Coordinating Center for Clinical Trials, Havana, Cuba.
PMID:
38597374
DOI:
10.1089/jir.2023.0193
No abstract available
Keywords:
COVID-19; Cuba; SARS-Cov-2; interferon.